Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check7 days agoChange DetectedPublications section updated with a new ATHENA MONO publication citation by Kristeleit et al. (Ann Oncol. 2026). The revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page’s revision tag was updated to v3.6.2, replacing v3.6.0, indicating a minor maintenance update with no changes to the study information visible to users.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now indicates that recruitment is no longer open to participants and adds new Help/Navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label and updates the revision note to v3.6.0.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study document revision was updated to v3.5.4, replacing the previous v3.5.3. This reflects a newer version of the protocol without additional visible content changes in the data provided.SummaryDifference0.0%

- Check65 days agoChange DetectedThe location entry has been updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305 in the Locations section. This clarifies the city designation for that site in the ATHENA study record.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.